• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health . Explaining the COVID19 mortality growth rate: an empirical analysis of Israeli cities

tetano

Editor, Senior Moderator
Front Public Health


. 2025 Jul 9:13:1548294.
doi: 10.3389/fpubh.2025.1548294. eCollection 2025. Explaining the COVID19 mortality growth rate: an empirical analysis of Israeli cities

Yuval Arbel[SUP] 1 [/SUP], Yifat Arbel[SUP] 2 [/SUP], Amichai Kerner[SUP] 3 [/SUP], Miryam Kerner[SUP] 4 5 [/SUP]



Affiliations
Abstract

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an infectious virus, which has generated a global pandemic. Since December 20, 2020, Israel was one of the first countries to vaccinate its population. This study analyzes the weight of four covariates on a daily mortality growth rate from SARS-COV2 virus. These include population size, median age, a socio-economic ranking at a city level, a date variable and a dummy variable that equals 1 for post-vaccination and 0 for pre-vaccination era.
Method: Regression analysis, where each variable is converted to the standard normal distribution function. This methodology permits the estimation of variations in daily mortality growth rates, where all the covariates are given in comparable units of measurement (one standard deviation). Consequently, the coefficients of this regression have to be measured as absolute value weights.
Results: Findings suggest a rise in projected mortality growth rate with population-size and median age, and a drop with socio-economic ranking and vaccination availability. Of the four investigated covariates, population size and median age of the city have the highest weight, whereas socio-economic ranking and vaccination availability have the lowest weight.
Conclusions: In an effort to reduce the mortality of severe coronavirus disease (COVID19) patients, greater priority should be given to larger cities with a relatively older population profile. In particular, policies should strive for better coordination at a municipal level between health and municipal and welfare services, particularly in large cities.

Keywords: COVID-19; median age; mortality; population size; socio-economic ranking.

 
Back
Top Bottom